Complete abrogation of key osteoclast markers with a membrane-anchored tissue inhibitor of metalloproteinase

Medicine and Dentistry

• Acid Phosphatase Tartrate Resistant Isoenzyme 20%
• Adenosine Triphosphatase 10%
• Bone 10%
• Cathepsin K 10%
• Dendritic Cell 10%
• Differentiation 10%
• Disease 20%
• Disintegrin 10%
• Extracellular Matrix 10%
• Hydroxamic Acid 10%
• Ligand 30%
• Marker Gene 10%
• Matrix Metalloproteinase 10%
• Membrane Protein 20%
• Messenger RNA 10%
• Metalloprotease Inhibitor 100%
• Metalloproteinase 20%
• Mitogen-Activated Protein Kinase 10%
• Nuclear Factor 30%
• Osteoclast 100%
• Osteoclastogenesis 20%
• Osteoporosis 10%
• Phosphatidylinositol 10%
• Receptor 40%
• Signal Transduction 10%
• Stem Cell 10%
• Therapeutic Procedure 20%
• Transcription Factor 10%
• Transcription Factor NFAT 20%

Biochemistry, Genetics and Molecular Biology

• A Disintegrin and Metalloproteinase 10%
• ATPase 10%
• Bone 10%
• Dendritic Cell 10%
• Glycosyl 10%
• Marker Gene 10%
• Matrix Metalloproteinase 10%
• Membrane 100%
• Messenger RNA 10%
• Metalloproteinase 10%
• Mitogen-Activated Protein Kinase 10%
• Modulation 10%
• Phosphatidylinositol 10%
• Signal Transduction 10%
• Spectrum 10%
• Tissue Inhibitor of Metalloproteinase 100%
• Transcription Factor 10%
• Transcription Factor NFAT 20%
• Transmembrane Protein 20%